Literature DB >> 11458427

A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model.

A J Taylor1, P D Gorman, B Kenwood, C Hudak, G Tashko, R Virmani.   

Abstract

The stent-artery interactions of different stent designs have implications for their clinical effects. We studied four different stent designs to compare their effects on arterial injury, cellular proliferation, neointima formation, and arterial dimensions. Eighteen nonatherosclerotic miniswine underwent random placement of 52 coronary stents (3.0 mm), including self-expanding nitinol stents (no postdilation; Radius, n = 13) and balloon-expandable stents (8 atm x 45 sec; Palmaz-Schatz, n = 13; BX, n = 12; and Multilink, n = 14). Cellular proliferation was determined by S-phase labeling with BrdU at 7, 14, and 28 days. Proliferation, injury scores, and arterial morphometry were blindly evaluated. All four stent designs had similar injury scores, cellular proliferation indexes (neointimal and medial), and adventitial areas. Nitinol stents resulted in a twofold increase in neointimal area and thickness in 28-day vessels (P = 0.002). However, lumen area was similar for all stent designs because of an offsetting expansion in vessel area in nitinol stents (20% greater than balloon-expandable stents) occurring between 7 and 14 days after stent deployment (P = 0.03). Reduced neointimal cell density in nitinol stents (20% less than balloon-expandable stents, P = 0.012) suggests that extracellular matrix expansion accounts for the larger neointima in nitinol stents. Self-expansion of nitinol stents within normal porcine arteries results in a similar degree of arterial injury compared to balloon-expandable stent designs. Progressive enlargement of nitinol stents between 7 and 14 days after deployment is associated with the development of a larger, matrix-rich neointima, with a preserved lumen area. Cathet Cardiovasc Intervent 2001;53:420-425. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458427     DOI: 10.1002/ccd.1194

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

1.  Nitinol Carbofilm coated stents for peripheral applications: study in the porcine model.

Authors:  M Prunotto; C Isaia; M A Gatti; E Monari; E Pasquino; M Galloni
Journal:  J Mater Sci Mater Med       Date:  2005-12       Impact factor: 3.896

2.  Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model.

Authors:  Masayuki Mori; Kenji Sakata; Chiaki Nakanishi; Takuya Nakahashi; Masa-Aki Kawashiri; Kazuaki Yoshioka; Yoh Takuwa; Hirofumi Okada; Jun-Ichiro Yokawa; Masaya Shimojima; Tsuyoshi Yoshimuta; Shohei Yoshida; Masakazu Yamagishi; Kenshi Hayashi
Journal:  Heart Vessels       Date:  2017-05-17       Impact factor: 2.037

Review 3.  Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury.

Authors:  Austin I McDonald; M Luisa Iruela-Arispe
Journal:  Vascul Pharmacol       Date:  2015-06-18       Impact factor: 5.773

4.  Effects of antiplatelet agents and other factors on neointimal proliferation in iliac artery stenting: intravascular ultrasound analysis.

Authors:  Hisao Kumakura; Hiroyoshi Kanai; Yoshihiro Araki; Akira Koizumi; Shu Kasama; Hiroyuki Sumino; Shuichi Ichikawa
Journal:  Ann Vasc Dis       Date:  2009-12-14

Review 5.  Drug eluting stents: are human and animal studies comparable?

Authors:  R Virmani; F D Kolodgie; A Farb; A Lafont
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

Review 6.  The representative porcine model for human cardiovascular disease.

Authors:  Yoriyasu Suzuki; Alan C Yeung; Fumiaki Ikeno
Journal:  J Biomed Biotechnol       Date:  2010-12-28

7.  A novel mouse model of in situ stenting.

Authors:  Janet Chamberlain; Mark Wheatcroft; Nadine Arnold; Henry Lupton; David C Crossman; Julian Gunn; Sheila Francis
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

8.  Drug-eluting coronary stents - focus on improved patient outcomes.

Authors:  Zehra Jaffery; Amit Prasad; John H Lee; Christopher J White
Journal:  Patient Relat Outcome Meas       Date:  2011-09-22

9.  Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine.

Authors:  Qi Zhang; Lin Lu; LiJin Pu; RuiYan Zhang; Jie Shen; ZhengBing Zhu; Jian Hu; ZhenKun Yang; QiuJin Chen; WeiFeng Shen
Journal:  Cardiovasc Diabetol       Date:  2007-06-05       Impact factor: 9.951

10.  Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness.

Authors:  Flavio Roberto Azevedo de Oliveira; Luiz Alberto Piva E Mattos; Alexandre Abizaid; Andrea S Abizaid; J Ribamar Costa; Ricardo Costa; Rodolfo Staico; Roberto Botelho; J Eduardo Sousa; Amanda Sousa
Journal:  Arq Bras Cardiol       Date:  2013-10-08       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.